P R E S S     R E L E A S E

Dialog Pharmaceutical, Biotech and Other Content Made Available at BioSpace Via New Alliance

CARY, N.C., USA, April 8, 2002 -- Dialog, a Thomson business and a leading worldwide provider of online-based information services and integrated information solutions, today announced an alliance with BioSpace, Inc., providers of the Web's most successful and popular site for information and resources for professionals in the life sciences arena.

Through the alliance announced today, Dialog has made portions of the content it collects from thousands of information providers around the world available through BioSpace's public Web site (www.biospace.com).

From anywhere within the BioSpace site, users are able to click through to the Dialog site where they may search for articles, reports and documents published in dozens of relevant databases maintained by Dialog. Users may purchase the full text of desired documents online using credit cards.

The initial Dialog content available to BioSpace users includes clinical databases, worldwide patents and related intellectual property documentation, world news focused on the pharmaceutical and biotechnology industries, and an extensive array of scientific literature.

"We are delighted to be working closely with BioSpace to offer their public Web site users access to some of the world's most authoritative life sciences content," said Gregg Kunz, Dialog senior vice president, alliances and business development. "We have long-standing ties with information providers around the world, and now through BioSpace can offer them to a larger audience of end-users in the life sciences field."

Added Michael Sterns, D.V.M., BioSpace executive vice president, corporate development: "Our new relationship with Dialog offers our users a powerful resource for in-depth scientific research, and for tracking companies, industries and markets in the life sciences field. We pride ourselves in being the world's most comprehensive site for life sciences news and information, and the addition of Dialog to our stable of content providers certainly adds to our premier standing."

BioSpace's Web site attracts more than one million unique visitors monthly. The company also offers a daily e-mail newsletter, the GenePool, which reaches 45,000 readers.

Specific sources now available through Dialog's BioSpace channel include:

Clinical Databases: Adis R&D Insight, Adis Newsletters, Derwent Drug File, IMS R&D Focus, DIOGENES® FDA Regulatory Updates, Drug Information Fulltext, International Pharmaceutical Abstracts, The Merck Index Online

Worldwide Patents: Derwent Patents Citation Index, French Patents, JAPIO, IMSworld Patents International, Chinese Patent Abstracts in English, European Patents Fulltext, U.S. Patents Fulltext, CLAIMS®/Current Patents Legal Status, CLAIMS®/U.S. Patents, WIPO/PCT Patents Fulltext

International BioNews: Pharmaceutical and Healthcare Industry News Database (PHIND), Asia-Pacific Business Journals, Asia-Pacific News, Asian Business Intelligence Reports, Canada NewsWire, Japan Economic Newswire(sm) Plus, JICST-EPlus - Japanese Science & Technology, South American Business Information, Sunday Star-Times (New Zealand), Times/Sunday Times (London), Toronto Star, South China Morning Post

Scientific Literature: MEDLINE®, EMBASE®, SciSearch®: a Cited Reference Science Database, Cancerlit®, Chemical Engineering and Biotechnology Abstracts, The Lancet®, Life Sciences Collection, TOXLINE®

- Ends -

About Dialog
Founded in 1972 by Dr. Roger K. Summit, a pioneer in developing the technology behind electronic information retrieval, Dialog is the world leader in providing online-based information services to organizations seeking competitive advantages in such fields as business, science, engineering, finance and law.

Today, Dialog's three online platforms -- Dialog®, Profound® and DataStar™ -- offer users the ability to precisely retrieve data from more than 1.2 billion unique records, accessible via the Internet or through delivery to enterprise intranets. The content available ranges from articles and reports published in thousands of publications to in-depth repositories of patents, trademarks and other intellectual property data.

Corporate librarians, knowledge managers and other information professionals at more than 25,000 business, professional and government organizations in more than 100 countries prize Dialog services for their breadth and depth of content, precision searching and speed.

Headquartered in Cary, N.C., USA, with direct operations in 32 countries throughout North American, Latin America, Europe, the Middle East, South Africa and the Asia Pacific, Dialog is a business of The Thomson Corporation. For more information about Dialog, please visit www.dialog.com. Or, please call (U.S./Canada) 800-3-DIALOG or (U.S.) 919-462-8600. Dialog's London office may be reached at (44) (0) 207-940-6900.

About The Thomson Corporation
The Thomson Corporation (www.thomson.com), with 2001 revenues of $7.2 billion, is a leading provider of integrated information solutions to business and professional markets worldwide. The Corporation's common shares are listed on the Toronto (TSE: TOC) and London stock exchanges.

-30-

All designated trademarks used herein are the property of The Dialog Corporation or its subsidiaries. Registered marks are registered by The Dialog Corporation or its subsidiaries with the U.S. Patent and Trademark Office. All other marks are trademarks or registered trademarks of their respective owners.

About BioSpace
BioSpace, Inc. is a specialized provider of Web-based products and information services to the life sciences. Recognizing the tidal wave of information being published in the life sciences, BioSpace has developed products and services that more efficiently access, deliver and share information. BioSpace's Enterprise Solutions are led by an information management software application, the BioSpace LInKS™ Solution. Additionally, the company's premier Web site, www.biospace.com, offers both public and subscription-based life sciences information and resources, including its competitive intelligence offering, the BioSpace CCIS™ Solution.

top